Log In
Print this Print this

Anti-Notch1, brontictuzumab (OMP-52M51)

  Manage Alerts
Collapse Summary General Information
Company OncoMed Pharmaceuticals Inc.
DescriptionHumanized IgG2 mAb against Notch 1 (NOTCH1)
Molecular Target Notch 1 (NOTCH1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today